March 16, 2023

The University of Cincinnati's Bingfang Yan's research team has received a $2.5 million National Institutes of Health grant to answer the question of how FDA-approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.

March 28, 2023

Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.

April 14, 2023

Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.